March 20, 2024 · Form 4 insider transaction
Pizzuti Dana sold 714 shares of Crinetics Pharmaceuticals, Inc. at $43.69 per share, a transaction worth $31.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.